The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFevertree Regulatory News (FEVR)

Share Price Information for Fevertree (FEVR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,145.00
Bid: 1,152.00
Ask: 1,159.00
Change: -15.00 (-1.29%)
Spread: 7.00 (0.608%)
Open: 1,120.00
High: 1,161.00
Low: 1,120.00
Prev. Close: 1,160.00
FEVR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

24 Jan 2018 07:00

RNS Number : 7223C
Fevertree Drinks PLC
24 January 2018
 

24th January 2018

Fevertree Drinks plc

 ("Fever-Tree", the "Group" or the "Company")

 

Trading Update

Fever-Tree, the world's leading supplier of premium carbonated mixers, is pleased to announce its trading update for the year ended 31 December 2017.

The Company has delivered another period of very strong growth with full year revenue expected to be circa £169 million, reflecting growth of 66% on 2016 with sales in the second half expected to be ahead of the prior year period by 58%.

The performance in the UK in the second half of 2017 has once again been exceptionally strong. The Company gained significant market share from its competitors culminating in Fever-Tree ending the year as the number one mixer brand by value in the UK off-trade channel. (IRI - Total UK Retail Mixer Market value share - 13 weeks to 31/12/17).

Full year revenue in the UK is expected to be circa 96% ahead of 2016. The Group's performance over the Christmas period was particularly notable with impressive rate of sales growth across all channels, formats and flavours. The growth of the mixer category continues to accelerate, driven by Fever-Tree's unwavering focus on quality and supported by the on-going premiumisation of the wider spirits sector.

Sales in Continental Europe performed well in the second half of 2017, and it is anticipated that full year revenue will be circa 42% ahead of 2016.

In the USA, strong revenue growth also continued during the second half of 2017, and as a result, full year revenue for the territory is expected to be circa 39% ahead of 2016. The establishment of a North American office and the appointment of Charles Gibb as North American CEO, announced in December 2017, were significant milestones and reflect the Group's ambition and commitment to the North American market.

Rest of World sales growth accelerated in the second half of 2017 and full year revenue is expected to be circa 57% ahead of 2016.

In view of the Company's very strong sales performance in the final two months of the year, the Group took the opportunity to bring forward planned operational expenditure in the US to invest ahead of growth. Year-end net cash position is anticipated to be in line with Board expectations with significant cash balances still to collect given the strength of trading over the Christmas period.

FY17 expectations

Reflecting the continued strong performance through to the end of the year, the Board expects that the outcome for the full year will be comfortably ahead of market expectations.

Fever-Tree will announce its Preliminary Results on 13th March 2018.

Commenting on today's announcement, Tim Warrillow, Co-founder and CEO of Fever-Tree said:

"I am very proud of our performance in 2017 which has seen Fever-Tree end the year as the number one mixer brand at UK retail. Our pioneering approach and commitment to providing consumers with the highest quality range of mixers continues to capture peoples' imagination and is transforming the wider UK mixer category which as a result is now the fastest growing category across the soft drinks sector.

While we have seen strong growth across all regions, our performance in the UK over the Christmas period was once again exceptional. Our growing range of mixers and formats are appealing not only to our loyal customers but also bringing consumers back to the category and importantly attracting a new younger audience.

There is clear evidence that the same trends of premiumisation and mixability that we've previously highlighted are accelerating and we are increasingly excited by the global opportunity this presents particularly as we transition to our own operations in the US."

 

 

For further information:

 

Fevertree Drinks plc

Tim Warrillow, Co-founder and CEO

Andy Branchflower, Finance Director

Oliver Winters, Communications Director

+44 (0)20 7349 4922

FTI Consulting - Financial PR

Jonathon Brill

Georgina Goodhew

Fiona Walker

+44 (0)20 3727 1000

fever-tree@fticonsulting.com

Investec Bank plc - Nominated Adviser and Broker

Garry Levin

Alex Wright

David Anderson

+44 (0)20 7597 5970

 

 

Notes to Editors:

 

Fever-Tree is the world's leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, with distribution to over 60 countries worldwide. Based in the UK, the brand was launched in 2005 to provide high quality mixers which could cater to the growing demand for premium spirits, in particular gin, but also increasingly for vodka, rum and whisky. The Company now sells a range of carbonated mixers to hotels, restaurants, bars and cafes ("On Trade") as well as selected retail outlets ("Off Trade").

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFFALIIVFIT
Date   Source Headline
15th Jul 202210:14 amRNSDirector/PDMR Shareholding
15th Jul 20227:00 amRNSHY pre-close trading update
1st Jul 20222:26 pmRNSFever Tree drinks plc Total Voting Rights
29th Jun 20227:00 amRNSStandard form for notification of major holdings
10th Jun 20228:45 amRNSNOTIFICATION OF MAJOR HOLDINGS
1st Jun 20227:00 amRNSDirector/PDMR Shareholding
1st Jun 20227:00 amRNSTotal Voting Rights
31st May 20227:00 amRNSBlock Listing Return
23rd May 20223:00 pmRNSDirector/PDMR Shareholding
19th May 202212:57 pmRNSResult of Annual General Meeting
19th May 20227:00 amRNSTrading Update
3rd May 20227:00 amRNSRetirement of Chair of the Board
28th Apr 20224:00 pmRNSGrant of Options
21st Apr 20225:00 pmRNSStandard form for notification of major holdings
20th Apr 202211:58 amRNS2021 Annual Report and Notice of AGM
21st Mar 20227:00 amRNSDirector/PDMR Shareholding
18th Mar 20227:00 amRNSCorrection to Dividend Shareholder Register Date
17th Mar 20224:23 pmRNSHolding(s) in Company
17th Mar 20227:00 amRNSHolding(s) in Company
16th Mar 20227:00 amRNSFY21 Preliminary Results to 31 December 2021
11th Mar 20227:00 amRNSHolding(s) in Company
1st Mar 20229:46 amRNSHolding(s) in Company
1st Feb 20227:00 amRNSTotal Voting Rights
28th Jan 20224:32 pmRNSHolding(s) in Company
27th Jan 20227:00 amRNSFY21 Trading Update
4th Jan 20229:18 amRNSTotal Voting Rights
1st Dec 20217:00 amRNSTotal Voting Rights
1st Dec 20217:00 amRNSChange of Registered Office
30th Nov 20217:00 amRNSBlock Listing Return
10th Nov 20217:00 amRNSDirector/PDMR Shareholding
1st Nov 20217:00 amRNSTotal Voting Rights
1st Oct 20217:00 amRNSTotal Voting Rights
15th Sep 20217:00 amRNSFY21 Interim Results to 30 June 2021
1st Sep 20217:00 amRNSTotal Voting Rights
28th Jul 20214:53 pmRNSHolding(s) in Company
20th Jul 20217:00 amRNSHolding(s) in Company
20th Jul 20217:00 amRNSFY21 Half Year Pre-Close Trading update
1st Jul 20217:00 amRNSTotal Voting Rights
28th Jun 20215:35 pmRNSHolding(s) in Company
28th Jun 202111:23 amRNSHolding(s) in Company
4th Jun 20217:00 amRNSHolding(s) in Company
4th Jun 20217:00 amRNSHolding(s) in Company
1st Jun 20212:26 pmRNSTotal Voting Rights
28th May 20217:00 amRNSBlock Listing Return
21st May 202111:21 amRNSGrant of Options
20th May 202112:37 pmRNSResult of Annual General Meeting
20th May 20217:00 amRNSAppointment of Non-Executive Director
20th May 20217:00 amRNSAGM Trading Update
4th May 20217:00 amRNSTotal Voting Rights
19th Apr 20214:15 pmRNS2020 Annual Report and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.